Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cochlear implantation for treatment-induced ototoxic deafness in Langerhans cell histiocytosis. A case report.

Literature DB >> 15942803

Cochlear implantation for treatment-induced ototoxic deafness in Langerhans cell histiocytosis. A case report.

Attila Torkos¹, Jeno Czigner, József Géza Kiss, Ferenc Tóth, Alice Szamosközi, József Jóri.

Abstract

A case is presented where the authors carried out a cochlear implantation on a girl whose deafness was induced by cytostatic agents. The normally hearing child was diagnosed with Langerhans cell histiocytosis at the age of 3 years and received polychemotherapy for almost 2 years. By her 5th year, she started to develop a bilateral, progressive sensorineural hearing loss, necessitating a hearing aid in both ears. While her histiocytosis was cured, her hearing ultimately deteriorated to total deafness on the right and profound hearing loss on the left ear. After 3 years, her hearing aids no longer provided adequate hearing for the postlingually deafened girl. At the age of 14, a cochlear implantation was performed on her right ear with excellent results.

Entities: Disease Species

Mesh：

Year: 2004 PMID： 15942803 DOI： 10.1007/s00405-004-0858-1

Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN： 0937-4477 Impact factor: 2.503

15 in total

1. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.

Authors: Milen Minkov; Nicole Grois; Andreas Heitger; Ulrike Pötschger; T Westermeier; Helmut Gadner
Journal: Med Pediatr Oncol Date: 2002-12

2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.

Authors: M Minkov; N Grois; A Heitger; U Pötschger; T Westermeier; H Gadner
Journal: Klin Padiatr Date: 2000 Jul-Aug Impact factor: 1.349

3. Case report: Langerhans cell histiocytosis of the temporal bone in children: Challenging diagnosis of a rare disease with some pitfalls.

Authors: Anja Pähler Vor der Holte; Hans-Jürgen Welkoborsky
Journal: Clin Case Rep Date: 2022-10-12

3 in total

Cochlear implantation for treatment-induced ototoxic deafness in Langerhans cell histiocytosis. A case report.

1. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.

2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.

Review 3. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.

4. Evaluation of long-term toxicity after chemotherapy for testicular cancer.

5. [Cochlear implant for children: indications and surgical aspects].

Review 6. Ototoxicity of chemotherapeutic agents.

7. PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness.

8. Cochlear implantation for progressive hearing loss.

9. High-dose cisplatin and etoposide in advanced malignancies of childhood.

10. Successful cochlear implantation in a child after recovery from a head and neck malignancy: a case report.

1. Cochlear Implantation after Bromate Intoxication-Induced Bilateral Deafness: A Case Report.

2. A Case of Cochlear Implantation in Bromate-Induced Bilateral Sudden Deafness.

3. Case report: Langerhans cell histiocytosis of the temporal bone in children: Challenging diagnosis of a rare disease with some pitfalls.